Security Snapshot

AbbVie Inc. - Common Stock (ABBV) Institutional Ownership

CUSIP: 00287Y109

13F Institutional Holders and Ownership History from Q1 2014 to Q3 2026

13F reference period

Q3 2026

Institutions Reporting

3,911

Shares (Excl. Options)

876.98MFull value: 876,980,951 · shares · 30 Sep 2026

Price

$261.59

The headline uses the Q3 2026 reference period after its reporting deadline. Available reports may still be incomplete or amended.

Save this security page for your next review

Watchlists follow companies and investors, across their share classes. Bookmark this page to revisit this specific CUSIP and its quarterly holders. If you create an account from here, we will bring you back after verification.

Latest holder snapshot 5 signals
Portfolio coverage rank
0.24%
Share change
+17,349,345
Value change
+$4,557,141,803
Number of holders
3,911
Issuer context Names, identifiers, and filing context for this profile. 3 identity fields
Shares outstanding
1,769,960,826
SEC-reported price per share
$290.79
Insider filing price
$290.79
13F Shares, Excluding Options vs Price
13F Value, Excluding Options
Total Investors
Filing notes and source

Key facts

  • ABBV - AbbVie Inc. - Common Stock is tracked under CUSIP 00287Y109.
  • 3911 institutions reported positions in Q3 2026.
  • 1 significant owner is listed from Schedule 13D/13G reporting.

Change

  • Holder count moved from 4,252 to 3,911 between Q2 2026 and Q3 2026.
  • SEC-reported value moved from
    $335.38BFull value: $335,382,628,703 · USD · 30 Jun 2026
    to
    $230.02BFull value: $230,016,650,049 · USD · 30 Sep 2026
    .

Research use

  • You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
  • 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.

Evidence

Source: SEC Form 13F

Latest holder context comes from 3911 institutions filings for Q3 2026.

Open SEC evidence

Security key

00287Y109

13F reference period

Q3 2026

13F holders

3,911

13D/G owners

1

CIK / CUSIP context first

13D/G owners

Significant owners

Large-stake holder rows connected to Schedule 13D/G evidence.

Rows
1
Security
ABBV
Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
VANGUARD CAPITAL MANAGEMENT LLC 7.5% $28,909,653,374 132,924,058 Vanguard Capital Management 31 Mar 2026
As of 30 Sep 2026, 3,911 institutional investors reported holding
876.98MFull value: 876,980,951 · shares · 30 Sep 2026
shares of AbbVie Inc. - Common Stock (ABBV). This represents 50% of the company’s total
1.77BFull value: 1,769,960,826 · shares · Stored outstanding share count
outstanding shares.

13F concentration

Top 25 institutional shareholders

Largest 13F positions for this security by reported shares and value.

Top holder share
29%
Institution Ownership % Shares Held Share Change % Portfolio % Holdings Value
VANGUARD CAPITAL MANAGEMENT LLC 6.5% 115,676,728 0.64% $30,259,875,278
STATE STREET CORP 4.7% 82,815,387 0.63% $21,663,677,085
VANGUARD PORTFOLIO MANAGEMENT LLC 2.8% 49,001,331 0.58% $12,818,258,176
GEODE CAPITAL MANAGEMENT, LLC 2.7% 47,503,777 0.64% $12,404,019,552
Capital Research Global Investors 1.8% 31,115,872 1.2% $8,139,628,876
BANK OF AMERICA CORP /DE/ 1.5% 26,386,673 0.44% $6,902,489,822
Capital World Investors 1.2% 20,653,641 0.66% $5,402,940,209
Capital International Investors 0.91% 16,171,164 0.88% $4,230,994,162
GOLDMAN SACHS GROUP INC 0.81% 14,369,942 0.42% $3,759,033,203
Legal & General Group Plc 0.65% 11,509,934 0.62% $3,010,883,630
WELLINGTON MANAGEMENT GROUP LLP 0.6% 10,705,904 0.5% $2,800,557,428
Fisher Asset Management, LLC 0.57% 10,063,539 0.76% $2,632,521,480
VANGUARD FIDUCIARY TRUST CO 0.56% 9,995,595 0.56% $2,614,747,696
RAYMOND JAMES FINANCIAL INC 0.56% 9,906,657 0.69% $2,591,482,470
Invesco Ltd. 0.38% 6,695,576 0.14% $1,751,495,840
DIMENSIONAL FUND ADVISORS LP 0.38% 6,637,840 0.32% $1,736,522,586
Mirabaud Asset Management Ltd 0.35% 6,200,000 1.5% $1,632,398,000
Janus Henderson Group Ltd. 0.34% 5,990,058 0.66% $1,567,106,422
Swiss National Bank 0.27% 4,832,410 0.67% $1,264,110,132
ENVESTNET ASSET MANAGEMENT INC 0.27% 4,795,011 0.27% $1,254,324,907
ALLIANCEBERNSTEIN L.P. 0.25% 4,344,902 0.35% $1,136,608,860
VANGUARD ASSET MANAGEMENT, Ltd 0.24% 4,298,191 0.7% $1,124,363,784
LPL Financial LLC 0.23% 4,142,781 0.23% $1,083,709,960
National Pension Service 0.23% 4,043,565 0.67% $1,057,756,168
NORDEA INVESTMENT MANAGEMENT AB 0.22% 3,933,975 0.82% $1,038,687,419

Quarter history

Institutional holders across reporting periods

Holder count, reported shares/value, and median price by quarter.

Periods
51
Headline period
Q3 2026
Rows shown
1-25 of 51
Period 13F Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2026 Q3 876,980,951 $230,016,650,049 +$4,557,141,803 $261.59 3,911
2026 Q2 1,333,815,890 $335,382,628,703 +$9,307,619,020 $251.64 4,252
2026 Q1 1,297,867,011 $281,932,841,619 -$4,987,617,867 $217.49 4,107
2025 Q4 1,317,975,937 $300,943,385,952 +$9,344,782,058 $228.49 4,135
2025 Q3 1,270,015,568 $293,795,490,662 -$3,123,583,240 $231.54 3,878
2025 Q2 1,287,075,518 $238,891,433,790 +$4,866,082,603 $185.62 3,742
2025 Q1 1,261,493,107 $264,023,235,689 -$2,130,141,483 $209.52 3,780
2024 Q4 1,275,092,654 $226,558,537,921 +$1,209,556,751 $177.70 3,709
2024 Q3 1,263,246,128 $249,268,364,641 +$88,413,171 $197.48 3,466
2024 Q2 1,262,725,926 $216,474,972,193 +$1,915,850,329 $171.52 3,339
2024 Q1 1,253,088,393 $227,875,219,935 +$2,788,759,396 $182.10 3,353
2023 Q4 1,239,748,668 $192,192,568,041 +$1,517,401,072 $154.97 3,297
2023 Q3 1,228,903,942 $183,197,476,249 +$1,009,113,820 $149.06 3,092
2023 Q2 1,221,315,614 $164,787,374,519 -$1,664,070,544 $134.73 3,053
2023 Q1 1,233,425,991 $196,519,460,228 +$259,081,467 $159.37 3,117
2022 Q4 1,235,502,434 $199,621,628,438 +$2,752,393,686 $161.61 3,144
2022 Q3 1,221,220,466 $164,097,646,774 +$170,284,213 $134.21 2,949
2022 Q2 1,217,745,031 $186,477,353,594 +$3,489,007,770 $153.16 2,980
2022 Q1 1,203,308,144 $195,040,563,504 +$2,450,810,000 $162.11 3,033
2021 Q4 1,188,323,728 $160,862,723,207 +$1,040,998,406 $135.40 2,954
2021 Q3 1,177,170,536 $127,005,644,713 -$384,320,770 $107.87 2,641
2021 Q2 1,182,050,895 $133,115,260,852 -$647,210,591 $112.64 2,657
2021 Q1 1,186,224,948 $128,344,178,557 -$1,087,268,478 $108.22 2,595
2020 Q4 1,197,885,694 $128,301,295,744 -$1,070,454,735 $107.15 2,580
2020 Q3 1,210,244,308 $105,941,681,033 -$1,507,877,911 $87.59 2,356
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .